HRMY Harmony Biosciences Holdings, Inc.
Pharmaceutical Preparations · Nasdaq · SEC EDGAR official
Market Value*
$1.32B
Revenue (FY)
$868.45M 2025-12-31
Net Income (FY)
$158.69M
P/E (float-based)
8.3
Pharmaceutical Preparations · Nasdaq · SEC EDGAR official